Novel therapeutic targets and potential drugs for BCG incurable non-muscle-invasive bladder cancer

被引：0
|
作者：
Zhou, P. [1 ]
Hu, H. [1 ]
Hu, J. [1 ]
Wang, S. [1 ]
机构：
[1] Tongji Hosp, Dep Urol, Wuhan, Peoples R China
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0072
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [1] NOVEL THERAPEUTIC TARGETS AND POTENTIAL DRUGS FOR BCG INCURABLE NON-MUSCLE-INVASIVE BLADDER CANCER
    Zhou Peng
    Hu Henglong
    Wang Shaogang
    JOURNAL OF UROLOGY, 2022, 207 (05): : E934 - E934
  • [2] Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer
    Moussa, Mohamad
    Papatsoris, Athanasios G.
    Dellis, Athanasios
    Abou Chakra, Mohamed
    Saad, Wajih
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (11) : 965 - 983
  • [3] Novel intravesical therapies for non-muscle-invasive bladder cancer refractory to BCG
    Barlow, LaMont J.
    Seager, Catherine M.
    Benson, Mitchell C.
    McKiernan, James M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (01) : 108 - 111
  • [4] BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
    Lidagoster, Sarah
    Ben-David, Reuben
    De Leon, Benjamin
    Sfakianos, John P.
    CURRENT ONCOLOGY, 2024, 31 (02) : 1063 - 1078
  • [5] Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics
    Slusarczyk, Aleksander
    Zapala, Piotr
    Zapala, Lukasz
    Piecha, Tomasz
    Radziszewski, Piotr
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (07) : 1089 - 1099
  • [6] Immunotherapy for non-muscle-invasive bladder cancer: from the origins of BCG to novel therapies
    Unsworth-White, Samantha R.
    Kitchen, Mark O.
    Bryan, Richard T.
    FUTURE ONCOLOGY, 2021, 18 (01) : 105 - 115
  • [7] Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics
    Aleksander Ślusarczyk
    Piotr Zapała
    Łukasz Zapała
    Tomasz Piecha
    Piotr Radziszewski
    International Urology and Nephrology, 2019, 51 : 1089 - 1099
  • [8] Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?
    Lindner, Andrea K.
    Klatte, Tobias
    Comperat, Eva
    Heidegger, Isabel
    Pichler, Renate
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (06) : 343 - 345
  • [9] BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets
    Claps, Francesco
    Pavan, Nicola
    Ongaro, Luca
    Tierno, Domenico
    Grassi, Gabriele
    Trombetta, Carlo
    Tulone, Gabriele
    Simonato, Alchiede
    Bartoletti, Riccardo
    Mertens, Laura S.
    van Rhijn, Bas W. G.
    Mir, Maria Carmen
    Scaggiante, Bruna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [10] What is the optimal BCG dose in non-muscle-invasive bladder cancer?
    Witjes, J. Alfred
    EUROPEAN UROLOGY, 2007, 52 (05) : 1300 - 1302
12345